Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04890093
Title Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

Advanced Solid Tumor

Ewing sarcoma

embryonal rhabdomyosarcoma

alveolar rhabdomyosarcoma


STA-8666 + Temozolomide + Vincristine Sulfate

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.